文献速递免疫规划传染病防控与疫情报告

高剂量流感疫苗预防老年人住院的效果评估及效果研究设计局限性的观察

Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design.
PubMed 文献 · Vaccine · 2018-10-01

该研究通过将免疫登记记录与住院数据链接,评估2016-17流感季高剂量(HD)流感疫苗预防老年人PCR确诊流感相关住院的差异效果。在23,712对匹配的HD与标准剂量接种老年人中,最终模型显示HD疫苗预防流感相关住院的效果高30.7%(95%CI:8-48%)。作者警告,非匹配或过于简单的匹配VE研究设计可能大幅低估疫苗效果。

要点

  • 高剂量流感疫苗在老年人中预防流感相关住院的效果比标准剂量高30.7%(95%CI:8-48%)。
  • 匹配方案中加入精确年龄、居住邮编等分层因素可提高VE估计值。
  • 非匹配或过于简单的匹配设计可能大幅低估疫苗效果。

核心结论

  • 高剂量流感疫苗为老年人预防流感相关住院提供了优于标准剂量的保护。

研究设计与样本

  • 研究将免疫登记记录与住院数据链接,评估2016-17流感季波特兰大都会区老年人HD疫苗预防PCR确诊流感住院的差异VE。
  • 采用嵌套系列模型分析匹配分层对VE的影响,最终模型纳入23,712对HD与SD匹配的老年人。
  • 匹配要素包括精确年龄、性别、居住类型、种族-民族、提供者偏倚和居住邮编。

主要发现

  • 简单的聚合比较显示HD疫苗无额外效果。
  • 嵌套模型中加入分层因素后VE估计值增加。
  • 最终模型中HD疫苗预防流感相关住院的效果比SD高30.7%(95%CI:8-48%)。

关键数值与推荐

  • 最终模型VE差异为30.7%(95%CI:8-48%),基于23,712对匹配老年人。

临床怎么用

  • 优先为老年人选择高剂量流感疫苗以降低流感相关住院风险。
  • 评估疫苗效果时需采用充分匹配的研究设计以避免低估VE。

局限性

  • 研究仅针对2016-17流感季波特兰大都会区,外推需谨慎。
  • 非匹配或过于简单的匹配VE设计可能大幅低估疫苗效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The availability of high-dose (HD) influenza vaccine for seniors should decrease influenza-related hospitalization. Studies to date show a range of mostly moderate increased HD vaccine effectiveness (VE). While a 'healthy vaccinee' phenomenon can inflate VE, for influenza and particularly an HD vaccine targeted at frailer adults, an 'at-risk vaccinee' bias may deflate VE estimates. We assessed senior HD vaccine effectiveness against influenza-related hospitalization by linking immunization registry records to hospitalizations. We also examined whether adding strata typically ignored in case-control matching schemas, such as residence areas, exact age, and provider biases, would increase VE. METHODS: For the 2016-17 influenza season in the Portland metropolitan area, the differential VE for the HD vaccine in preventing PCR-confirmed influenza hospitalization was assessed by a nested series of models across matching strata. For an exact match for high-dose and standard-dose seniors, matching elements included exact age, gender, residence type, race-ethnicity, provider bias, and residence area (zipcode). RESULTS: As a first step, a simple aggregate comparison of influenza-related hospitalization risk showed no added HD effectiveness. For the nested models, adding strata increased VE. In the final model, among 23,712 matched pairs of HD to SD vaccinated seniors, the HD vaccine was 30.7% (95%CI: 8-48%) more effective in preventing influenza-related hospitalization. CONCLUSION: For this study, the high-dose influenza vaccine provided superior protection for seniors against influenza hospitalization. Including matching elements as exact year of age and residence zipcode all added to the calculation of VE. As a warning, non-matched or overly simple matched VE study designs may substantially under-estimate VE.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Robison SG, Thomas AR. Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design. Vaccine. 2018. PMID: 30287157. doi:10.1016/j.vaccine.2018.09.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。